![](/img/cover-not-exists.png)
A phase I dose-escalation study of Selumetinib in combination with Erlotinib or Temsirolimus in patients with advanced solid tumors
Infante, Jeffrey R., Cohen, Roger B., Kim, Kevin B., Burris, Howard A., Curt, Gregory, Emeribe, Ugochi, Clemett, Delyth, Tomkinson, Helen K., LoRusso, Patricia M.Language:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-017-0459-7
Date:
April, 2017
File:
PDF, 500 KB
english, 2017